FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

359133006: Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    473283018 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1457647013 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478040014 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    473283018 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    473283018 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    727971017 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1195109013 Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1457647013 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1457647013 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478040014 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1478040014 Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial Is a Galactose microparticles (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Galactose (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial Has manufactured dose form Injection (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Contrast media (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start